Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Reader Login  
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:2777

Official publication of the Indian Society of Nephrology
  ~   Site Statistics 
  ~   Addresses 
  ~   Search 
  ~   My Preferences 
  ~   Online Submission 


Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2020| May-June  | Volume 30 | Issue 3  
    Online since June 11, 2020

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
“Infodemic” of COVID 19: More pandemic than the virus
Mohan P Patel, Vivek B Kute, Sanjay K Agarwal, On behalf of COVID-19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):188-191
Coronavirus disease (COVID 19), which was started in Wuhan, China in December 2019 has become a pandemic, leading to unprecedented risk to the human race. However, fear wave accelerating ahead of pandemic worldwide is driven by prejudice or erroneous information. This has been termed as “infodemics” by WHO considering its fake nature, which triggered discrimination and stigma of disease along with the failure of rapid response policies. Additionally, the lack of adequate pandemic preparedness plans identified in many countries may be responsible for infodemics. NonCOVID medical illnesses have taken a back seat at many places while implementing COVID 19 control strategies and patients are diverted to COVID 19 screening hospitals leading to a potential health crisis. Now, we also have to focus on mitigating infodemics and its implications at the social front while strategic planning to control current and future pandemics.
  7,396 473 14
Renal transplant guidelines with reference to COVID-19 infection
Vivek Kute, Santosh Varugese, Narayan Prasad, Sunil Shroff, Sanjay Kumar Agarwal, On Behalf of COVID 19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):176-178
Development of COVID-19 pandemic has affected organ transplant activity significantly. To start with, government of India had adviced stoppage of “elective” surgeries so as to cope with resources and manpower for COVID-19 patients. As majority of hospitals are having both COVID and Non-COVID patients, there is obvious fear of cross-infection. Also, transplant patients being immunocompromised, there is higher risk of acquiring COVID-19 infection along with atypical presentation and unpredicted course of the disease. Result was that across India, elective living related kidney transplant came to a halt. Cadaver renal transplant, being emergency in nature still done, though very few. With passing time, once it became clear that pandemic is not going to be controlled sooner, need has been felt to restart renal transplant activity. Keeping various issues in mind in relation to elective living related renal transplant and emergency deceased donor renal transplant, these guidelines have been framed to help transplant professionals for restarting renal transplant program again in the country, while keeping both health care workers and patient safe.
  5,299 372 3
COVID 19 and acute kidney injury
Narayan Prasad, Sanjay K Agrawal, On behalf of COVID-19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):161-165
Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome-corona virus (SARS-CoV-2), a beta coronavirus, mainly involves the respiratory tract, and the clinical features simulate to a severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) of the past. The genome of the SARS-CoV-2, isolated from a cluster-patient with a typical pneumonia after visiting Wuhan, had 89% nucleotide identitical with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. It enters the respiratory tract through angiotensin converting enzyme-2 (ACE2) receptors on alveoli. It may induce lung injury through direct cytopathic effect, involving effector T cells or causing sepsis and inducing cytokine storm.With a similar mechanism, it can cause acute kidney injury (AKI). The overall incidence of AKI is 5.1%, and AKI is an independent risk factor for mortality. The hazard ratio of death increases with the increasing severity of AKI. Management of COVID-19 with AKI is primarily supportive care, and at present, there are no evidence based effective antivirals for the treatment.
  5,256 381 10
Epidemiology, genomic structure, the molecular mechanism of injury, diagnosis and clinical manifestations of coronavirus infection: An overview
Narayan Prasad, N Gopalakrishnan, Manisha Sahay, Amit Gupta, Sanjay K Agarwal, On behalf of Covid-19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):143-154
COVID-19 is caused by a novel beta coronavirus (SARS-CoV-2) strain that was first discovered in 2019 in the Wuhan city of China. Based on virus genome sequencing studies, the bat is suspected as the natural host of virus, and infection might be transmitted from bats via unknown intermediate hosts like reptiles and snakes etc., to infect humans. COVID-19 is transmitted from person to person contact, primarily via droplet infection within the incubation period or after clinical manifestations of fever, cough, sneezing, sputum, dyspnea, and pneumonia and through contaminated fomites. COVID-19 enters the respiratory tract through the ACE2 receptor on alveoli through binding of s-protein of the virus and causes injuries though the cytopathic effect, as well as cytokines and other mediators, released after developing sepsis. ACE 2 is almost 100-fold higher in kidneys than lung, and the virus can also involve the kidney in the same manner. Kidney involvement manifests in the form of proteinuria, hematuria, and an acute rise in serum creatinine. Kidney involvement is an independent risk factor for mortality. Diagnosis is primarly made by detecting viral RNA by reverse transcriptase polymerase chain reaction (rtPCR) in nasopharyngeal swab samples. Role of antibodies, both IgM and IgG are still evolving and at best restricted for epidemiological purpose. Though a large number of treatments, including hydroxychloroquine, anti-viral, convalescent plasma etc., are being tried, as of now treatment is symptomatic only.
  5,065 350 4
Peritoneal dialysis patients during COVID 19 pandemic
Tarun Jeloka, Amit Gupta, Narayan Prasad, Santosh Varughese, Sandeep Mahajan, KS Nayak, Sanjay Kumar Agarwal, Georgi Abraham, On behalf of COVID-19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):171-173
COVID pandemic poses challenges to peritoneal dialysis patients, caretaker, and service provider to the PD patients as well. The chronic peritoneal dialysis (PD) patients are trained to do the PD procedure at home, therefore can avoid in-center hospital visit unlike patients on hemodialysis. Thus, PD patients can avoid undue exposure to the novel coronavirus. The PD can be offered in COVID induced AKI patients, even in remote places where hemodialysis cannot be offered. The paper is aimed to provide guidelines about the safe use of PD and treatment of complications during the COVID pandemic.
  2,973 237 1
Short Term Renal Outcome of Bortezomib Based Therapy in Patients with Multiple Myeloma Requiring Dialysis
Alok Kumar Pandey, Dhananjai Agarwal, Vinay Rathore, Gaurav Sekhar Sharma, Shyam Sunder Nowal, Pankaj Beniwal, Rajesh Jhorawat, Vinay Malhotra, Sanjeev Sharma
May-June 2020, 30(3):213-214
  2,814 389 -
Guidelines for dialysis with reference to COVID-19
Valentine Lobo, Umesh Khanna, Mohan Rajapurkar, Himanshu Sekhar Mahapatra, Himanshu Verma, Narayan Prasad, Sanjay K Agarwal, On behalf of Indian Society of Nephrology
May-June 2020, 30(3):166-170
  2,779 281 3
Solitary pelvic ectopic kidney and limb anomalies: Rare variant of acrorenal syndrome
Malsawmkima Chhakchhuak, Jony Agarwal
May-June 2020, 30(3):207-208
  2,782 169 1
Anti-corona Drugs: Current scenario
Edwin Fernando, Sishir Gang, Narayan Prasad, Arpita Roy Chaudhary, Sanjay Kumar Agarwal, On behalf of COVID 19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):179-184
  2,700 160 -
Infection prevention and control guidelines for COVID
Sandeep Mahajan, HS Kohli, KL Gupta, Narayan Prasad, Sanjay K Agarwal, On behalf of COVID19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):185-187
  2,665 121 -
Glomerular diseases with reference to COVID-19
Sanjeev Gulati, Narayan Prasad, Manisha Sahay, Vivek Kute, Sanjay K Agarwal, On behalf of COVID-19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):158-160
COVID pandemic affected every individual across the world. Patients with primary glomerular disease and glomerular disease secondary to systemic diseases who are on moderate to high doses of immunosuppression are at an increased risk of COVID because of their immunosuppressed state. The data to quantify the degree of risk in relation to the amount of immunosuppression or their duration of use is not robust. The patients on immunosuppression need to modify the drugs balancing the risk relapse and flare of the disease, simultaneously minimizing the risk of developing COVID. We tried to develop a guideline about the modification of the treatment regimen in such conditions.
  2,322 200 1
Rare, yet emerging cause of graft dysfunction—ALECT 2 amyloidosis
Kulwant Singh, Jasmine Sethi, Rajan Duggal, Kusum Joshi, Arjinder S Bains
May-June 2020, 30(3):204-206
Amyloidosis is characterized by pathological deposition of abnormal protein aggregates in various tissues, AL protein being the commonest. Amyloidosis derived from leukocyte cell-derived chemotaxin 2 (LECT2) is a recently recognized form of amyloidosis in the United States with predominant involvement of kidney and liver. We present a case of ALECT2 renal amyloid in a transplant recipient who presented with gradual worsening of graft function and subnephrotic proteinuria. To our knowledge, this is first case of LECT2 amyloidosis from Northern India in a transplant recipient. There is no effective therapy for amyloidosis derived from leukocyte cell-derived chemotaxin 2.
  2,152 177 -
Chronic kidney disease and hypertension with reference to COVID-19
Manish Rathi, Tarun Jeloka, Narayan Prasad, Shyam Bansal, Sanjay Kumar Agarwal, AK Bhalla, On behalf of COVID-19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):155-157
  2,031 220 1
COVID 19 and hemodialysis anxiety
Mohan P Patel, Vivek B Kute, Narayan Prasad, Sanjay K Agarwal, On behalf of COVID-19 Working Group of Indian Society of Nephrology
May-June 2020, 30(3):174-175
  2,067 178 3
Covid-19: Why the kidney care is so much affected?
Sanjay K Agarwal, Narayan Prasad
May-June 2020, 30(3):141-142
  1,904 140 -
Lymphomatous interstitial nephritis coexistent with paraneoplastic crescentic membranoproliferative glomerulonephritis in a case of mantle cell lymphoma
Praveen Kumar Etta, MV Rao, Sujeet Reddy, Swarnalata Gowrishankar, Neha Agarwal
May-June 2020, 30(3):192-195
Mantle cell lymphoma (MCL) is a rare aggressive lymphoproliferative disorders (LPD) of B-cell lymphoma, which usually presents in advanced stages at initial diagnosis. Renal involvement in MCL is very rare, especially the combined presence of both glomerular and interstitial disease. We report on a patient with lymphomatous interstitial nephritis (LIN) coexistent with paraneoplastic crescentic membranoproliferative glomerulonephritis (MPGN), subsequently diagnosed to have disseminated MCL with bone marrow and lymph nodal infiltration. He was treated with rituximab-based chemotherapy and went into complete renal remission at 6-months of follow up.
  1,831 170 1
A case of intra-abdominal abscess due to sphingomonas paucimobilis in a patient on peritoneal dialysis: A case report and review of literature
Lim Chiao Yuen, Tan Jackson
May-June 2020, 30(3):196-200
Sphingomonas paucimobilis is an aerobic gram-negative bacillus, widely distributed in the water and soil. It has also been found in nosocomial environments causing nosocomial infections. S. paucimobilis is a rare cause of peritoneal dialysis (PD)-related peritonitis. Here, we report the 14th case, with a literature review. Our case is unique as this is the first reported case of intra-abdominal abscess associated with S. paucimobilis PD-related peritonitis.
  1,808 162 2
Page kidney complicating kidney biopsy after stopping Apixaban: A physician's dilemma
Macaulay A. C. Onuigbo, Vivek Sharma, Omotola Balogun, Allina Ghimire
May-June 2020, 30(3):201-203
Page kidney was described by Page, following very elaborate experiments with animal kidneys in 1939, with persistent arterial hypertension from “cellophane perinephritis.” Subsequently, it was reported after trauma, from renal cysts and tumors, and from intrarenal hematoma complicating percutaneous kidney biopsy. We describe Page kidney associated with acute kidney injury 26 days after an uncomplicated ultrasound-guided right native kidney biopsy. Patient was on Apixaban, a non-vitamin K antagonist oral anticoagulant (NOAC) for atrial fibrillation which was withheld 3 days before the procedure. It was restarted 3 days after. The evidence-base supporting guidelines and recommendations for the peri-procedural management of the NOACs is inadequate, sparse, and often conflicted. More research is warranted.
  1,777 149 -
Clopidogrel induced thrombotic microangiopathy successfully treated with conservative approach
Praveen Kumar Etta, Swarnalata Gowrishankar
May-June 2020, 30(3):209-210
  1,682 184 -
Guillain-Barre syndrome in a pregnant-live-related ABO-incompatible renal allograft recipient
Praveen K Etta, Sreepada Subhramanyam, Karopadi S Nayak
May-June 2020, 30(3):211-212
  1,566 158 -
Professor Rabindra Nath Sahoo 24.08.1949 - 21.05.2020
Chittaranjan Kar
May-June 2020, 30(3):0-0
  896 70 -
Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07